Nancy G. Iskander

594 total citations
5 papers, 429 citations indexed

About

Nancy G. Iskander is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Nancy G. Iskander has authored 5 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Nancy G. Iskander's work include Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Nancy G. Iskander is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Nancy G. Iskander collaborates with scholars based in United States. Nancy G. Iskander's co-authors include Apostolia M. Tsimberidou, Aung Naing, Sijin Wen, Jennifer J. Wheler, Razelle Kurzrock, David S. Hong, Sarina A. Piha‐Paul, Siqing Fu, Gerald S. Falchook and Filip Jankú and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Nancy G. Iskander

5 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy G. Iskander United States 3 295 218 199 116 83 5 429
David Mallery United States 4 329 1.1× 247 1.1× 212 1.1× 130 1.1× 87 1.0× 5 498
Amy Krie United States 5 268 0.9× 257 1.2× 172 0.9× 172 1.5× 80 1.0× 10 527
Pam K. Mangat United States 12 322 1.1× 468 2.1× 273 1.4× 140 1.2× 99 1.2× 47 644
H. Roché France 12 183 0.6× 303 1.4× 190 1.0× 117 1.0× 91 1.1× 24 551
Ninad Dewal United States 6 305 1.0× 194 0.9× 206 1.0× 228 2.0× 75 0.9× 9 514
Andrew L. Rygiel United States 8 159 0.5× 251 1.2× 151 0.8× 82 0.7× 37 0.4× 12 332
Patricia Gómez Spain 8 257 0.9× 486 2.2× 182 0.9× 155 1.3× 36 0.4× 16 653
David Edward Lebwohl United States 8 158 0.5× 503 2.3× 117 0.6× 110 0.9× 34 0.4× 11 686
Shunji Kamigaki Japan 10 279 0.9× 329 1.5× 141 0.7× 66 0.6× 46 0.6× 31 461
Maggie Wilcox United Kingdom 6 304 1.0× 340 1.6× 168 0.8× 65 0.6× 83 1.0× 9 512

Countries citing papers authored by Nancy G. Iskander

Since Specialization
Citations

This map shows the geographic impact of Nancy G. Iskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy G. Iskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy G. Iskander more than expected).

Fields of papers citing papers by Nancy G. Iskander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy G. Iskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy G. Iskander. The network helps show where Nancy G. Iskander may publish in the future.

Co-authorship network of co-authors of Nancy G. Iskander

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy G. Iskander. A scholar is included among the top collaborators of Nancy G. Iskander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy G. Iskander. Nancy G. Iskander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Tsimberidou, Apostolia M., Nancy G. Iskander, David S. Hong, et al.. (2012). Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative. Clinical Cancer Research. 18(22). 6373–6383. 387 indexed citations
2.
Tsimberidou, Apostolia M., Sijin Wen, Jennifer J. Wheler, et al.. (2011). Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience. Clinical Cancer Research. 17(12). 4110–4118. 18 indexed citations
3.
Tsimberidou, Apostolia M., Nancy G. Iskander, David S. Hong, et al.. (2011). Personalized medicine in a phase I clinical trials program: The M. D. Anderson Cancer Center Initiative.. Journal of Clinical Oncology. 29(18_suppl). CRA2500–CRA2500. 22 indexed citations
4.
Tsimberidou, Apostolia M., David S. Hong, Jennifer J. Wheler, et al.. (2011). Abstract 4410: Initiative for Molecular Profile and Advanced Cancer Therapy (IMPACT): A personalized medicine Phase I clinical trials program at MD Anderson Cancer Center. Cancer Research. 71(8_Supplement). 4410–4410. 1 indexed citations
5.
Tsimberidou, Apostolia M., David S. Hong, Jennifer J. Wheler, et al.. (2011). Abstract 1287: Profile-related evidence to determine individualized cancer therapy (PREDICT): Preliminary results of the Personalized Phase I Clinical Trials program at MD Anderson Cancer Center. Cancer Research. 71(8_Supplement). 1287–1287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026